Herramientas para la evaluación integral de la función sexual en pacientes con esclerosis múltiple

Gaviria-Carrillo, Mariana; Salas, Paola Andrea Ortiz; Vergara, Karla; Bernal, Guillermo; Nava-Mesa, Mauricio O.; Medina, K. Moreno

doi:10.1016/j.nrl.2020.04.028

Cited by 5 publications

(3 citation statements)

References 47 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Although up to 5 scales, including the Female Sexual Function Index , International Index of Erectile Function , Sexual Expectations Evaluation in Women with Multiple Sclerosis , or the Szasz Sexual Functioning Scale have been described that could be used to assess sexual dysfunction in people with MS. However, the latter questionnaires only evaluate sexual dysfunctions in one sex or do not address sexuality from the broad spectrum of causes that can lead to problems in people with MS ( Carrillo et al, 2020 ). Therefore, the MSISQ-15 questionnaire and its original 19-item version, the MSISQ-19 ( Sanders et al, 2000 ) that has also been validated in other settings ( Nehrych et al, 2019 ; Silva et al, 2015 ; Mohammadi et al, 2014 ; Devis et al, 2022 ; Carotenuto et al, 2021 ), could be the best option for assessing sexuality in people with MS because they consider the three possible causes of sexual dysfunction.…”

Section: Discussionmentioning

confidence: 99%

“…Therefore, the MSISQ-15 questionnaire and its original 19-item version, the MSISQ-19 ( Sanders et al, 2000 ) that has also been validated in other settings ( Nehrych et al, 2019 ; Silva et al, 2015 ; Mohammadi et al, 2014 ; Devis et al, 2022 ; Carotenuto et al, 2021 ), could be the best option for assessing sexuality in people with MS because they consider the three possible causes of sexual dysfunction. In turn, this could help guide health professionals in the design and application of interventions aimed at improving the sexuality of patients with MS ( Carrillo et al, 2020 ).…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Validation and cross-cultural adaptation of the Multiple Sclerosis Intimacy and Sexuality Questionnaire-15 (MSISQ-15) into Spanish

Ríos

Cabañero‐Martínez

Escribano

et al. 2023

PeerJ

View full text Add to dashboard Cite

Background The Multiple Sclerosis Intimacy and Sexuality Questionnaire-15 (MSISQ-15) is a valid and reliable tool to assess the sexuality of people with multiple sclerosis. The objectives of this study were: 1) to cross-culturally adapt and examine the psychometric properties of the MSISQ-15 in the Spanish context and 2) to examine the association between sexual dysfunction and other related factors. Methods We conducted a instrumental study. People diagnosed with multiple sclerosis and members of multiple sclerosis associations in Spain were included. The linguistic adaptation of the questionnaire was performed through a translation-back translation procedure. For the psychometric validation, the confirmatory factor analysis was used while the internal consistency was examined by the ordinal alpha test. The construct validity was examined by correlating the results with the Male Sexual Function (FSH), Female Sexual Function-2 (FSM-2), Dyadic Adjustment Scale-13 (EAD-13) and Multiple Sclerosis International Quality of Life Questionnaire (MusiQoL) questionnaires. Results A total of 208 participants were included. Both the fit of the Spanish version of the MSISQ-15 to the original scale and the internal consistency were adequate (α = 0.89). The construct validity showed correlations with the FSH, FSM-2, and MusiQoL but not with the EAD-13. Conclusions The Spanish version of the MSISQ-15 is a valid and reliable tool to assess the sexuality of people with multiple sclerosis in the Spanish context.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Validation and cross-cultural adaptation of the Multiple Sclerosis Intimacy and Sexuality Questionnaire-15 (MSISQ-15) into Spanish

Ríos

Cabañero‐Martínez

Escribano

et al. 2023

PeerJ

View full text Add to dashboard Cite

show abstract

“…La EM es una enfermedad autoinmune, desmielinizante y crónica del sistema nervioso central (SNC), que afecta a aproximadamente 2.3 millones de personas en todo el mundo (3). Su incidencia y prevalencia varían ampliamente, pero es más común en las latitudes más altas, y afecta con mayor frecuencia a las mujeres que a los hombres (4).…”

Section: Introductionunclassified

Esclerosis múltiple: el rol de los agentes neuroprotectores en la progresión y nuevos estudios sobre remielinización

Berrezueta-Sigüenza,

Ochoa-Bravo

2023

MQRInvestigar

View full text Add to dashboard Cite

La esclerosis múltiple (EM) es una enfermedad autoinmune crónica del sistema nervioso central que se manifiesta mediante la desmielinización y neurodegeneración. A pesar de los avances significativos en el tratamiento, sigue siendo una causa principal de discapacidad en adultos jóvenes. Esta revisión se enfoca en investigar el papel emergente de los agentes neuroprotectores en la progresión de la EM y examinar las estrategias de remielinización en desarrollo. Metodología: Se realizó una revisión bibliográfica extensa centrada en la esclerosis múltiple y el uso de agentes neuroprotectores y estrategias de remielinización. Los agentes neuroprotectores, como la ocrelizumab, el natalizumab y el fingolimod, demuestran potencial para limitar la neurodegeneración y posiblemente influir en la progresión de la enfermedad. Por otra parte, las terapias de remielinización, que tienen como objetivo reparar la mielina dañada, incluyendo el anticuerpo anti-LINGO-1, la clemastina, y la biotina de alta dosis, están mostrando resultados prometedores en los ensayos preclínicos y clínicos. A pesar de los desafíos significativos, incluyendo la necesidad de biomarcadores más efectivos y de comprender mejor la biología de la remielinización, los avances en este campo son alentadores. Las terapias combinadas que incorporan agentes inmunomoduladores, neuroprotectores y remielinizantes podrían convertirse en un enfoque estándar para el tratamiento de la EM en el futuro, mejorando considerablemente la calidad de vida de los pacientes con EM.

show abstract

Multiple Sclerosis and Sexual Dysfunction

Sepúlveda Gázquez

2024

Trends in Andrology and Sexual Medicine

View full text Add to dashboard Cite

Herramientas para la evaluación integral de la función sexual en pacientes con esclerosis múltiple

Cited by 5 publications

References 47 publications

Validation and cross-cultural adaptation of the Multiple Sclerosis Intimacy and Sexuality Questionnaire-15 (MSISQ-15) into Spanish

Validation and cross-cultural adaptation of the Multiple Sclerosis Intimacy and Sexuality Questionnaire-15 (MSISQ-15) into Spanish

Esclerosis múltiple: el rol de los agentes neuroprotectores en la progresión y nuevos estudios sobre remielinización

Multiple Sclerosis and Sexual Dysfunction

Contact Info

Product

Resources

About